Decision-Making for Preventive Interventions in Asymptomatic Patients.

Area of Science:

• Medical Decision-Making
• Clinical Risk Assessment
• Health Economics

Background:

• Deciding on treatment for asymptomatic incidental findings is complex.
• Balancing immediate intervention risks against long-term conservative management risks is crucial.
• Current decision-making may lead to overtreatment.

Purpose of the Study:

• To identify common errors in risk-benefit analysis for asymptomatic incidental findings.
• To propose an improved decision-making framework.
• To advocate for an outcome-based approach over a risk-based one.

Main Methods:

• Critique of the traditional risk-based approach using Kaplan-Meier curves.
• Illustration of the limitations of the break-even point analysis.
• Advocacy for an outcome-based approach measuring cumulative quality-adjusted life years (QALYs) lost.

Main Results:

• Risk-based approaches, particularly relying on Kaplan-Meier curve crossing, can be misleading.
• The timing of adverse events (immediate for intervention vs. gradual for conservative) impacts true benefit.
• The cumulative loss of QALYs reveals a later emergence of treatment benefit.

Conclusions:

• Overtreatment of asymptomatic diseases can be avoided by shifting from risk-based to outcome-based decision-making.
• Cumulative quality-adjusted life years lost provide a more accurate measure of treatment benefit.
• Clinical practice should prioritize outcome-based evaluation for incidental findings.